Effects of Immunosuppression Induced by Thalidomide and Cyclosporine in Heterotopic Heart Transplantation in Rabbits

Transplantation Proceedings

Volumn 39, Issue 5, 2007, Pages 1640-1641

  Carvalho, J B V ^a   Petroianu, A ^a   Travolo, E ^a   de Oliveira, B H ^a   Duarte, A B B ^a   Alberti, L R ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; THALIDOMIDE;

ANIMAL EXPERIMENT; ARTICLE; CARDIAC GRAFT REJECTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; HETEROTOPIC TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS;

ANIMALS; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; MALE; MODELS, ANIMAL; RABBITS; SURVIVAL ANALYSIS; THALIDOMIDE; TRANSPLANTATION, HETEROTOPIC;

EID: 34250223000     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.02.072     Document Type: Article

References (3)

1. Miller S., Sharda S., Rodrigue J., et al. Thalidomide in chronic graft-versus-host disease after stem cell transplantation: effects on quality of life. Int J Hematol 76 (2002) 365
2. Mann F.C., Priestley J.T., and Markowitz U. Transplantation of the intact mammalian heart. Heart Ann Surg 26 (1933) 219
3. Chaves D.N.B., Petroianu A., Alberti L.R., et al. Effects of thalidomide, cyclosporine, and diclofenac on skin allograft survival in rabbits. Transplant Proc 33 (2004) 1018